DrugPatentWatch Database Preview
Drugs in Development Information for Butylphthalide
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Butylphthalide?
Butylphthalide is an investigational drug.
There have been 13 clinical trials for Butylphthalide.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2015.
The most common disease conditions in clinical trials are Stroke, Ischemia, and Cerebral Infarction. The leading clinical trial sponsors are CSPC-NBP Pharmaceutical Co., Ltd., Peking Union Medical College Hospital, and The Second Hospital of Hebei Medical University.
Summary for Butylphthalide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 159 |
| WIPO Patent Applications | 71 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 3 (2015-07-01) |
| Vendors | 52 |
Recent Clinical Trials for Butylphthalide
| Title | Sponsor | Phase |
|---|---|---|
| Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion | The Second Hospital of Hebei Medical University | Phase 4 |
| Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia | CSPC-NBP Pharmaceutical Co., Ltd. | Phase 3 |
| Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia | Capital Medical University | Phase 3 |
Clinical Trial Summary for Butylphthalide
Top disease conditions for Butylphthalide
Top clinical trial sponsors for Butylphthalide
US Patents for Butylphthalide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
